Seoul, South Korea

Seung Lyeol Lee

This inventor holds 1 USPTO granted patent. Top assignees: Healthconnect Co., Ltd., Invites Healthcare Co., Ltd.. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seung Lyeol Lee: Innovator in Diabetes Management

Introduction

Seung Lyeol Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of diabetes management through his innovative methods and systems. His work focuses on improving the quality of life for individuals living with diabetes.

Latest Patents

Seung Lyeol Lee holds a patent for a diabetes management method and system. This patent outlines a diabetes management server that includes a database defining a monitoring procedure for at least two patient groups. When the server receives a blood sugar measurement value from a user terminal, it generates feedback information based on the monitoring procedure for the relevant patient group. This feedback is then transmitted to the user terminal, providing valuable insights for diabetes management. He has 1 patent to his name.

Career Highlights

Throughout his career, Seung Lyeol Lee has worked with various companies, including Healthconnect Co., Ltd. and Invites Healthcare Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to diabetes management.

Collaborations

Seung Lyeol Lee has collaborated with notable individuals in his field, including Young Min Cho and Soo Heon Kwak. These partnerships have contributed to the advancement of his research and the implementation of his patented technologies.

Conclusion

Seung Lyeol Lee is a dedicated inventor whose work in diabetes management has the potential to significantly impact the lives of many individuals. His innovative methods and collaborative efforts continue to drive advancements in healthcare technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…